Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06907225 · ClinicalTrials.gov registry record

Physiological Responses to Heat Stress During High-risk Events

A clinical trial, sponsored by United States Army Research Institute of Environmental Medicine.

Recruiting
Registry status
150
Enrollment target

NCT06907225 is a clinical trial that is actively recruiting participants, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06907225 is actively recruiting participants, sponsored by United States Army Research Institute of Environmental Medicine.

RECRUITING
Registry status
150 participants
Enrollment target

Study Summary

Exertional heat stroke (EHS) affects \~500 Military Personnel and over 100 Soldiers every year, and it is believed that these numbers are underreported. EHS is the most severe form of exertional heat illness (EHI) and can result in substantial, long-lasting organ damage, and even death in severe cases. Based on current knowledge and training needs, it is impossible to prevent every EHS - which shifts the focus from exclusively prevention to a combination of prevention, treatment, and enhancing recovery as much as possible. While many risk factors have been identified and there are adequate treatments available, biomarkers associated with heat stroke risk, recovery, and return-to-duty (RTD) remain largely unclear. The purpose of the proposed study is to enhance knowledge surrounding biomarkers of EHS and long-term health consequences that result from EHS. The investigators will recruit research volunteers for a field study in order to collect pre-, post-, and follow-up measures from a high-risk EHS event (i.e. ruck marches, timed runs) this will allow us to have a basis for comparison between Soldiers who collapse with EHS (from previously collected data) and those that complete high-risk events, but do not collapse. This will allow for comparison between the groups to identify EHS-specific biomarkers that could aid in recovery and RTD decisions for Soldiers.

Interventions

  • OTHER None-placebo

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-05-31
Est. Completion 2026-09

What the Registry Record Tells You About NCT06907225

The ClinicalTrials.gov registry entry for NCT06907225 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which None-placebo is the first listed.

NCT06907225 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06907225 about?

NCT06907225 is a clinical study titled "Physiological Responses to Heat Stress During High-risk Events". Exertional heat stroke (EHS) affects \~500 Military Personnel and over 100 Soldiers every year, and it is believed that these numbers are underreported. EHS is the most severe form of exertional heat illness (EHI) and can result in substantial, long-lasting organ damage, and even death in severe cas...

What is the current status of trial NCT06907225?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-05-31. Estimated completion is 2026-09.

What interventions are being tested in trial NCT06907225?

The interventions under investigation include: None-placebo (OTHER).

Who is sponsoring clinical trial NCT06907225?

This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.